The clinical outcomes of mixed engraftment patients treated with haploidentical stem cells combined with umbilical cord blood transplantation

Yujie Liu; Lijuan Qi; Tanzhen Wang; Biqi Zhou; Jia Chen; Jinyan Xiao; Yanglan Fang; Qiannan Yang; Yufeng Feng; Depei Wu; Yang Xu

doi:10.1080/10428194.2022.2086245

The clinical outcomes of mixed engraftment patients treated with haploidentical stem cells combined with umbilical cord blood transplantation

Leuk Lymphoma. 2022 Nov;63(11):2696-2700. doi: 10.1080/10428194.2022.2086245. Epub 2022 Jun 18.

Authors

Yujie Liu^{1

2}, Lijuan Qi^{1

2}, Tanzhen Wang^{1

2}, Biqi Zhou^{1

2}, Jia Chen^{1

2}, Jinyan Xiao^{1

2}, Yanglan Fang^{1

2}, Qiannan Yang^{1

2}, Yufeng Feng^{1

2}, Depei Wu^{1

2}, Yang Xu^{1

2}

Affiliations

¹ Jiangsu Institute of Hematology, National Clinical Research Center for Hematologic Diseases, The First Affiliated Hospital of Soochow University, Suzhou, PR China.
² Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, PR China.

PMID: 35719092
DOI: 10.1080/10428194.2022.2086245

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Cord Blood Stem Cell Transplantation* / adverse effects
Fetal Blood
Graft vs Host Disease* / etiology
Graft vs Host Disease* / prevention & control
Hematopoietic Stem Cell Transplantation* / adverse effects
Humans
Transplantation Conditioning